An autoinflammatory disease due to homozygous deletion of the IL1RN locus

N Engl J Med. 2009 Jun 4;360(23):2438-44. doi: 10.1056/NEJMoa0809568.

Abstract

We describe a patient with an autoinflammatory disease in which the main clinical features are pustular rash, marked osteopenia, lytic bone lesions, respiratory insufficiency, and thrombosis. Genetic studies revealed a 175-kb homozygous deletion at chromosome 2q13, which encompasses several interleukin-1 family members, including the gene encoding the interleukin-1-receptor antagonist (IL1RN). Mononuclear cells, obtained from the patient and cultured, produced large amounts of inflammatory cytokines, with increasing amounts secreted after stimulation with lipopolysaccharide. A similar increase was not observed in peripheral-blood mononuclear cells from a patient with neonatal-onset multisystem inflammatory disorder (NOMID). Treatment with anakinra completely resolved the symptoms and lesions.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / genetics*
  • Chromosomes, Human, Pair 2 / genetics
  • DNA / isolation & purification
  • Gene Deletion*
  • Homozygote
  • Humans
  • Infant, Newborn
  • Inflammation / drug therapy
  • Inflammation / genetics
  • Inflammation / immunology*
  • Interleukin 1 Receptor Antagonist Protein / deficiency
  • Interleukin 1 Receptor Antagonist Protein / genetics*
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use
  • Male
  • Oligonucleotide Array Sequence Analysis
  • Sequence Analysis, DNA

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • DNA